SummaryRMgm-5542
|
||||||||||
*RMgm-5542| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene tagging, Introduction of a transgene |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 38396332 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Thieleke-Matos C, Frischknecht F,Singer M |
| Name Group/Department | Integrative Parasitology, Center for Infectious Diseases |
| Name Institute | Heidelberg University Medical School |
| City | Heidelberg |
| Country | Germany |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-5542 |
| Principal name | Uis4-TSR- GFP- CSP |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Not tested |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | High numbers of salivary gland-derived fluorescent sporozoites are produced, but their fluorescence was weak and variable. |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation To investigate CSP function by live fluorescence microscopy, we recently generated a series of P. berghei parasites expressing internally tagged CSP-GFP fusion proteins (Singer & Frischknecht, 2021; see mutants RMgm-4901). A replacement of CSP with a CSP-GFP fusion where the GFP was inserted between the signal peptide and the N-terminus allowed sporozoite formation. However, sporozoites degenerated within the cysts, and the CSP-GFP fusion was not detectable at the plasma membrane but within internal membranes suggesting processing of the protein shortly after the fusion protein was made. In contrast, two other internally tagged proteins allowed CSP-GFP expression and correct plasma membrane localization, albeit they were only expressed as additional copies from the csp locus. In these parasite lines, the GFP was inserted between either the repeats and the TSR (R-GFP-CSP) or the TSR and the GPI anchor (TSR-GFP-CSP). This allowed full sporozoite formation and targeted the protein to the plasma membrane. Yet, these parasites failed to egress from oocysts (Singer & Frischknecht, 2021; see mutants RMgm-4901).
|
Tagged: Mutant parasite with a tagged gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0403200 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0304600 | ||||||||||||||||||||||||||
| Gene product | circumsporozoite (CS) protein | ||||||||||||||||||||||||||
| Gene product: Alternative name | CSP | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Name of the tag | GFP | ||||||||||||||||||||||||||
| Details of tagging | C-terminal | ||||||||||||||||||||||||||
| Additional remarks: tagging | The mutant expresses a GFP-tagged version of CSP. The GFP-tagged csp gene is under control of the uis4 (PBANKA_0501200) promoter and is introduced in a locus on chromosome 12 between the genes PBANKA_122210 and PBANKA_122220. | ||||||||||||||||||||||||||
| Commercial source of tag-antibodies | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | To generate the vector for GFP-TSR rplc, the 3′ UTR of CSP used for integration was amplified with P278 P279, digested with HindIII KpnI and cloned into Pb238. The promoter region of CSP including the SP was amplified with P208 P268, digested with EcoRI and PshAI and ligated into the vector. Then, the GPI-anchored sequence including the 3′ UTR was amplified with P274 P576, digested with KasI BamHI and ligated into the vector. Prior to transfection the vector was linearized using PmeI and EcoRI. Genotyping was performed with P267 P210 (for 5′ UTR) resulting in 1298 bp, 3′ integration with P234 P882 resulting in 1187 bp and the whole locus PCR resulting in 6044 bp as well as 3051 bp for WT. For the generation of the R-GFP-CSP replacement construct, the downstream homology region in the extended 3′ untranslated region of CSP was amplified using the primers KW-39 and KW-36 from PbANKA genomic DNA. The fragment was integrated by digest and ligation with HindIII and XhoI into the previously established plasmid containing the R-GFP-CSP construct. The plasmid was digested with EcoRI and XhoI and integrated via homologous recombination, replacing the endogenous CSP. Alternative homologous recombination of the same construct allowed for the generation of the CSP Ctrl. rplc parasite line. Genotyping of 5′ integration and 3′ integration was confirmed through PCR amplification with the primers KW-60 with P210 and P187 with KW-61, respectively. The whole-length fragment is amplified with primers KW-60 and KW-61. Promoter-swapped TSR-GFP-CSP constructs were generated by amplification of the spect2 and uis4 5′ promoter regions with the primers Spect2-GA1 and Spect2-GA3 and GA1 and GA3, respectively. An additional fragment was amplified spanning the N-terminal CSP region and GFP with the primers Spect2-GA2 and GA4 for the Spect2-TSR-CSP-GFP construct and the primers GA2 and GA4 for the UIS4-TSR-CSP-GFP construct. The previously established TSR-GFP-CSP containing plasmid was digested using EcoRI and PvuII. The fragments were integrated into the vector backbone (NEBuilder Hifi DNA assembly). The plasmid was digested with PvuI and integrated via homologous recombination in a silent genomic region on chromosome 12. 5′ integration and 3′ integration were confirmed through PCR amplification with the primers P135 with P210 and P135 with P137, respectively. The whole-length fragment is amplified using P134 and P137. T Prior to transfection, the correct sequence of all plasmids was confirmed via Sanger sequencing | ||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
Transgene: Mutant parasite expressing a transgene| top of page | |||||||||||||||||||
| Type and details of transgene | |||||||||||||||||||
| Is the transgene Plasmodium derived | Transgene: Plasmodium | ||||||||||||||||||
| Gene Model of Parasite | PBANKA_0403200 | ||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0304600 | ||||||||||||||||||
| Gene product | circumsporozoite (CS) protein | ||||||||||||||||||
| Gene product: Alternative name | CSP | ||||||||||||||||||
| top of page | |||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||
| Additional remarks genetic modification | To generate the vector for GFP-TSR rplc, the 3′ UTR of CSP used for integration was amplified with P278 P279, digested with HindIII KpnI and cloned into Pb238. The promoter region of CSP including the SP was amplified with P208 P268, digested with EcoRI and PshAI and ligated into the vector. Then, the GPI-anchored sequence including the 3′ UTR was amplified with P274 P576, digested with KasI BamHI and ligated into the vector. Prior to transfection the vector was linearized using PmeI and EcoRI. Genotyping was performed with P267 P210 (for 5′ UTR) resulting in 1298 bp, 3′ integration with P234 P882 resulting in 1187 bp and the whole locus PCR resulting in 6044 bp as well as 3051 bp for WT. For the generation of the R-GFP-CSP replacement construct, the downstream homology region in the extended 3′ untranslated region of CSP was amplified using the primers KW-39 and KW-36 from PbANKA genomic DNA. The fragment was integrated by digest and ligation with HindIII and XhoI into the previously established plasmid containing the R-GFP-CSP construct. The plasmid was digested with EcoRI and XhoI and integrated via homologous recombination, replacing the endogenous CSP. Alternative homologous recombination of the same construct allowed for the generation of the CSP Ctrl. rplc parasite line. Genotyping of 5′ integration and 3′ integration was confirmed through PCR amplification with the primers KW-60 with P210 and P187 with KW-61, respectively. The whole-length fragment is amplified with primers KW-60 and KW-61. Promoter-swapped TSR-GFP-CSP constructs were generated by amplification of the spect2 and uis4 5′ promoter regions with the primers Spect2-GA1 and Spect2-GA3 and GA1 and GA3, respectively. An additional fragment was amplified spanning the N-terminal CSP region and GFP with the primers Spect2-GA2 and GA4 for the Spect2-TSR-CSP-GFP construct and the primers GA2 and GA4 for the UIS4-TSR-CSP-GFP construct. The previously established TSR-GFP-CSP containing plasmid was digested using EcoRI and PvuII. The fragments were integrated into the vector backbone (NEBuilder Hifi DNA assembly). The plasmid was digested with PvuI and integrated via homologous recombination in a silent genomic region on chromosome 12. 5′ integration and 3′ integration were confirmed through PCR amplification with the primers P135 with P210 and P135 with P137, respectively. The whole-length fragment is amplified using P134 and P137. T Prior to transfection, the correct sequence of all plasmids was confirmed via Sanger sequencing | ||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||
| top of page | |||||||||||||||||||
| Other details transgene | |||||||||||||||||||
| top of page | |||||||||||||||||||
| Promoter | |||||||||||||||||||
| Gene Model of Parasite | PBANKA_0501200 | ||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_1016900 | ||||||||||||||||||
| Gene product | early transcribed membrane protein 10.3 | protein of early gametocyte 4 | ||||||||||||||||||
| Gene product: Alternative name | UIS4; ETRAMP10.3 | ||||||||||||||||||
| |||||||||||||||||||
| top of page | |||||||||||||||||||
| 3'-UTR | |||||||||||||||||||
| Gene Model of Parasite | PBANKA_0403200 | ||||||||||||||||||
| Gene product | circumsporozoite (CS) protein | ||||||||||||||||||
| Gene product: Alternative name | CSP | ||||||||||||||||||
| |||||||||||||||||||
| Insertion/Replacement locus | |||||||||||||||||||
| Replacement / Insertion | Insertion locus | ||||||||||||||||||
| Gene Model of Parasite | Not available | ||||||||||||||||||
| Gene product | Not available | ||||||||||||||||||
| Gene product: Alternative name | |||||||||||||||||||
| |||||||||||||||||||
| top of page | |||||||||||||||||||